Digital Health Global

MARCH 2, 2023

Koneksa’s digital biomarker solutions include an industry-leading platform that gives research sponsors and clinical sites the ability to seamlessly aggregate data in real-time from devices, ePROs, patient diaries, and clinical assessments to provide the full picture of an individual’s health.

Life Science 88

Life Science Drug Development BioTech Leadership 88

Digital Health Global

JUNE 13, 2023

We’re on a mission to revolutionize drug development in clinical trials by harnessing the power of our digital solutions with real-time, data-driven insights. Koneksa’s extensive commitment to research includes the potential for industry participation in studies.

Drug Development 88

Drug Development eMed BioTech Digital Health 88

Digital Health Global

JANUARY 8, 2024

AI-powered* platform takes eCOA off the critical path to study startup for life sciences industry PALO ALTO, Calif.–(BUSINESS Early application of the technology in electronic clinical outcomes assessment (eCOA) deployments – a major delay to study startup industry-wide – is groundbreaking.

Life Science 88

Life Science Drug Development Pharmaceuticals HIPAA 88

Healthcare IT Today

JANUARY 8, 2024

The excitement around new tools took hold of all industries in 2023, and the potential is expansive. The unification of technology, services and pharmacovigilance expertise in the coming year will further enunciate the industry’s focus on patient safety. Dave Latshaw, CEO at BioPhy 1.

Health IT 85

Health IT Drug Development Pharmaceuticals BioTech 85

Lloyd Price

NOVEMBER 21, 2023

Palantir's products are used by a variety of industries, including healthcare. The company believes that its products can help to transform the healthcare industry. Overall, Palantir's software is helping to improve patient care, accelerate research, and improve drug development. Visit www.nelsonadvisors.co.uk

Drug Development 70

Drug Development Health science healthcare technology Leadership 70

Digital Health Global

MARCH 26, 2024

Indivi is committed to developing and validating novel digital endpoints in neuro-degenerative diseases (multiple sclerosis, Parkinson’s and Alzheimer’s diseases). Contacts For more information: Guilhem Dupont, CEO, guilhem.dupont@Indivi.io

Health Technology 88

Health Technology Digital Health BioTech Drug Development 88

Lloyd Price

MAY 16, 2023

Palantir's products are used by a variety of industries, including healthcare. The company believes that its products can help to transform the healthcare industry. Overall, Palantir's software is helping to improve patient care, accelerate research, and improve drug development. Buy, build or partner?

Drug Development 91

Drug Development Health science Pharmaceuticals Public Health 91

Digital Health Global

APRIL 16, 2024

Innovative and flexible, Medable Total Consent helps our industry move beyond simply relying on traditional paper consents.” Block, MD, Associate Chief Medical Officer and SVP of Clinical Research and Medical Affairs at U.S. Renal Care. The product was straightforward to use, and its training demo modules made it easy to implement.

Drug Development 88

Drug Development Pharmaceuticals Health science Digital Health 88

Digital Health Global

MAY 10, 2023

The healthcare industry is experiencing a significant transformation, with technology playing a vital role in modernizing medical practices and enhancing health outcomes. Patient experience has become a primary focus in our industry, and the digital transformation has provided new ways to enhance it.

Patient Experience 167

Patient Experience Mobile Health Telemedicine Drug Development 167

Healthcare IT Today

MAY 22, 2023

.” Prognos Health’s platform is used by over 70 life sciences customers to accelerate the development of new drugs, improve the safety and efficacy of existing drugs, and identify new patient populations that may benefit from specific treatments.

Life Science 60

Life Science Drug Development Health IT Healthcare IT 60

Digital Health Global

SEPTEMBER 27, 2023

About Automera Automera is an early-stage company focused on the development of a novel therapeutic approach via autophagy-based targeted protein degradation. ALSP’s portfolio companies are backed by renowned life science investors and are comprised of industry-leading, transformative companies, including KayoThera, Inc.,

Life Science 88

Life Science Drug Development HC BioTech 88

Healthcare IT Today

JULY 20, 2023

We are particularly excited about the ability of these tools to drive more efficient and faster drug development processes in the biopharma industry.” “The Flywheel uses AI to unlock the value within medical imaging data, signaling the continued benefit of applying AI across the healthcare industry.”

Life Science 66

Life Science Healthcare Innovation Drug Development Pharmaceuticals 66

Healthcare IT Today

MARCH 15, 2024

We’re already seeing the benefits of AI-infused research in pharmaceuticals and drug development. According to WEF , the largest ten pharmaceutical companies have either partnered with or acquired AI companies to make use of AI-assisted drug development and design.

Pharmaceuticals 94

Pharmaceuticals Drug Development Mental health Nursing 94

Lloyd Price

MAY 2, 2024

Exec Summary: Nvidia's strategy for healthcare revolves around leveraging their expertise in high-performance computing and AI to revolutionise various aspects of the healthcare industry. To support their strategy, Nvidia recently acquired both Deci and Run AI, making a significant move in the AI landscape.

healthcare technology 73

healthcare technology Drug Development Leadership Digital Health 73

Healthcare IT News - Telehealth

FEBRUARY 11, 2022

The companies drew particular attention to Labcorp Drug Development, which Ascension says it can use to present physicians and patients with access to clinical trials, innovative therapies and new treatment options where appropriate. Labcorp also said it would use proprietary analytic tools and processes to improve overall efficiency.

Drug Development 142

Drug Development Healthcare IT 142

Digital Health Global

NOVEMBER 2, 2023

I addressed six challenges in the healthcare industry, starting with unhealthy lifestyles. Drug development The traditional drug discovery process is characterized by its protracted timeline, high costs, and significant attrition rates among drug candidates. DiMasi, H.G. Grabowski, and R.W.

Drug Development 88

Drug Development Pharmaceuticals Public Health Telehealth 88

Lloyd Price

DECEMBER 11, 2023

Transforming healthcare A report from the London School of Economics, The Role of Virtual Health Care and the Pharmaceutical Sector in Improving Population Health , published in 2021, forecast that the pharmaceutical industry would be a core player in all aspects from population health management to preventive and therapeutic care.

Pharmaceuticals 64

Pharmaceuticals Digital Health Drug Development Life Science 64

Healthcare IT Today

NOVEMBER 1, 2022

Deerfield invests across the life science, medical device, diagnostic, digital health, and health service industries at every stage of evolution. The company will use this new funding to further expand its real-world data platform and services in order to drive more efficient and inclusive drug development in oncology.

Life Science 86

Life Science Drug Development Digital Health Health IT 86

GNS Healthcare

AUGUST 1, 2019

The thought of gathering massive amounts of data, from claims to EHR to molecular and making it easily accessible for drug development research once seemed impossible, as did getting at previously 'undruggable' pathways that defied the effects of even the most innovative drugs.

Drug Development 52

Drug Development EHR Healthcare Innovation 52

Society for Participatory Medicine

JANUARY 27, 2022

The same definition of patient engagement applies to industry, except that the interventions lead to more human centered design and value-based care. Stacy Hurt, MHA, MBA works as a Patient Engagement Consultant to represent the consumer perspective in clinical decision making, health IT user experience, and pharma/biotech drug development.

BioTech 107

BioTech Life Science Drug Development Patient Experience 107

Healthcare IT Today

OCTOBER 6, 2023

“We look forward to our strategic collaboration with Atropos Health to support the international expansion of its technology, which we believe will be at the forefront of the healthcare industry’s adoption of evidence-based informatics to enhance therapeutic results and lower the total cost of care.”

Life Science 103

Life Science Drug Development Pharmaceuticals Health IT 103

Digital Health Global

JANUARY 31, 2024

A Tufts Center for the Study of Drug Development study shows that, on average, decentralized trials can achieve net financial benefits from five to 13 times for Phase II and Phase III trials, equating to roughly $10 million ROI and $39 million ROI for an investment of on average of $500K in Phase 2 and $1.5M in Phase 3.

Health science 88

Health science Drug Development Digital Health Patient Experience 88

Healthcare IT News - Telehealth

MAY 29, 2020

“These technologies can also be leveraged by pharmaceutical companies to monitor the results of the drugs developed by them," said Ashish Kaul, technical insights senior research analyst at Frost & Sullivan. THE LARGER CONTEXT. ON THE RECORD.

Mental health 133

Mental health Drug Development Pharmaceuticals Telehealth 133

Lloyd Price

MAY 6, 2024

Exec Summary: AI has revolutionised the weather industry by providing faster, more accurate, and personalised weather predictions. This has significant benefits for public safety, disaster preparedness, and various industries that rely on weather information. Email lloyd@nelsonadvisors.co.uk

healthcare technology 70

healthcare technology Leadership Drug Development Digital Health 70

Health Populi

APRIL 29, 2019

In the past couple of months, Amazon announced many health-related plans and developments, including: Accepting medical and health savings accounts (HSAs) to pay for consumer health products like over-the-counter drugs. See more on that recommendation, and subsequent social media frenzy, here on Health Populi ).

HIPAA 305

HIPAA Drug Development Digital Health Mental health 305

Lloyd Price

FEBRUARY 20, 2020

Only outsiders, who come entirely unconditioned by industry experience and cultural thinking, are able to radically reimagine the solution to a problem.” The industry is now moving from a structure that treats sick people to one which, through AI, is predicting and preventing illness and disease.

mHealth 83

mHealth Drug Development Digital Health 83

GNS Healthcare

AUGUST 1, 2019

The thought of gathering massive amounts of data, from claims to EHR to molecular and making it easily accessible for drug development research once seemed impossible, as did getting at previously 'undruggable' pathways that defied the effects of even the most innovative drugs.

Drug Development 40

Drug Development EHR Healthcare Innovation 40

Healthcare Innovation Consortium

OCTOBER 24, 2023

We aim to bring together relevant stakeholders, including payers, providers, patients groups, and biotech and when and where needed we cooperate with pharma, to be the one voice of the industry. The pipeline for new antibiotics is limited, which is partly due to how new drug development is funded.

BioTech 60

BioTech Drug Development Healthcare Innovation Medical Technology 60

Healthcare IT Today

JULY 25, 2022

AI/ML is revolutionizing the healthcare industry,” said Schiess. The most advanced teams spend precious time developing internal tools to tackle aspects of this issue, but rarely have the staff, focus or time to create a comprehensive solution. But in order for an AI system to work, datasets must be complete, and they must be accurate.

Life Science 83

Life Science Drug Development Digital Health Health Data 83

Healthcare IT Today

JANUARY 23, 2024

Drug population and drug protocol fit account for nearly 75% of these failures. By simulating trials at scale, QuantHealth’s platform can lower risks, expedite, and optimize drug development. Petra Jantzer, Ph.D., Petra Jantzer, Ph.D.,

Drug Development 94

Drug Development Pharmaceuticals Life Science BioTech 94

Digital Health Global

FEBRUARY 16, 2023

Their expertise in company building, capital formation, and drug development will be a tremendous resource to Avilar as the innovation leader in the new field of extracellular protein degradation.”

Life Science 88

Life Science BioTech Drug Development Digital Health 88

Digital Health Global

APRIL 10, 2023

Aviceda Glycotech looks forward to this collaboration aimed at developing the next generation of cancer checkpoint immune therapeutics in Belfast. “It Co-Founder & President, and Chief Executive Officer.

Life Science 88

Life Science BioTech Drug Development Health science 88

Healthcare IT Today

DECEMBER 27, 2022

Future releases of Dynamyx will also create opportunities for Fujifilm to support pharmaceutical and contract research organizations with toxicity testing data management for drug development. “A The company operates as the strategic headquarters for the region.

Pharmaceuticals 60

Pharmaceuticals Drug Development Medical Technology Healthcare IT 60

Lloyd Price

FEBRUARY 18, 2024

Mergers and acquisitions: The promising future of GLP-1s led to several mergers and acquisitions within the healthtech industry. These deals aimed to consolidate market share, expand research capabilities, and accelerate product development, further stimulating investor interest.

Pharmaceuticals 60

Pharmaceuticals healthcare technology Leadership Drug Development 60

Healthcare IT Today

FEBRUARY 28, 2020

New healthcare AI and Machine Learning research conducted by Healthcare IT Today suggests that many industry leaders are serious about adopting healthcare AI and machine learning tools and what’s more, that these technologies are being used as part of mission-critical efforts rather than one-off pilot tests.

Health IT 87

Health IT Healthcare IT Drug Development Patient Experience 87

Insulin Nation

OCTOBER 16, 2015

In October, FierceBiotech reported that the company pulled the plug on the development of evacetrapib, a drug meant to ward off heart attacks and strokes, after investing $90 million in costly clinical trials. Lilly has endured a steady string of failed drug development in recent years, according to the report.

Pharmaceuticals 97

Pharmaceuticals Drug Development 97

Healthcare IT Today

NOVEMBER 14, 2022

Brad Whitmore is a successful investor who has targeted a broad range of investments across various industries with an emphasis on businesses with long-term, sustainable competitive advantages and unique offerings relative to competitors. Within Life Sciences, the firm focuses on MedTech, Diagnostics, and Opportunistic Drug Development.

Life Science 95

Life Science HIPAA Drug Development healthcare technology 95